Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.47 |
| ▸ | DRD3 | P35462 | 2/20 | 0.47 |
| ▸ | DRD1 | P21728 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.43 |
| ▸ | HTR3A | P46098 | 4/20 | 0.40 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.40 |
| ▸ | HTR3B | O95264 | 1/20 | 0.40 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.40 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 2/20 | 0.39 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31051722 | 0.94 | DRD2 (0.43) | DRD2DRD3DRD1HTR2ASIGMAR1 | |
| SCHEMBL31051724 | 0.79 | DRD2 (0.67) | DRD2DRD3DRD1HTR2ASIGMAR1 | |
| SCHEMBL31051920 | 0.78 | ADRB1 (0.61) | DRD2DRD3DRD1HTR2ASIGMAR1 | |
| SCHEMBL31052182 | 0.78 | ADRB1 (0.61) | DRD2DRD3DRD1HTR2ASIGMAR1 | |
| SCHEMBL31051787 | 0.77 | ADRB1 (0.38) | HTR2AADRB1HTR3AHTR7HTR1A | |
| SCHEMBL31052033 | 0.77 | ADRB1 (0.38) | HTR2AADRB1HTR3AHTR3EHTR3B | |
| SCHEMBL31052062 | 0.74 | HTR6 (0.42) | ADRB1HTR3AHTR3EHTR3BHTR3D | |
| SCHEMBL31052014 | 0.74 | HTR6 (0.42) | ADRB1HTR3AHTR1A | |
| SCHEMBL31051838 | 0.72 | DRD2 (0.47) | DRD2DRD3DRD1HTR2ASIGMAR1 | |
| SCHEMBL31052008 | 0.69 | DRD2 (0.47) | DRD2DRD3DRD1HTR2ASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678188-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING, OR MANAGING BILIRUBIN-INDUCED NEUROLOGICAL DYSFUNCTION, PSYCHIATRIC DISORDERS ASSOCIATED WITH JAUNDICE, OR PSYCHIATRIC DISORDERS CAUSED BY BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE GENE MUTATIONS | Ohnishi, Arata (JP) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024185842-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING, OR MANAGING BILIRUBIN-INDUCED NEUROLOGICAL DYSFUNCTION, PSYCHIATRIC DISORDERS ASSOCIATED WITH JAUNDICE, OR PSYCHIATRIC DISORDERS CAUSED BY BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE GENE MUTATIONS | 国立大学法人島根大学 | 2024-09-12 | — | — | WO | disclosed |